Cargando…
Impact of Advanced Radiotherapy on Second Primary Cancer Risk in Prostate Cancer Survivors: A Nationwide Cohort Study
PURPOSE: External Beam Radiotherapy (EBRT) techniques dramatically changed over the years. This may have affected the risk of radiation-induced second primary cancers (SPC), due to increased irradiated low dose volumes and scatter radiation. We investigated whether patterns of SPC after EBRT have ch...
Autores principales: | Jahreiß, Marie-Christina, Heemsbergen, Wilma D., van Santvoort, Bo, Hoogeman, Mischa, Dirkx, Maarten, Pos, Floris J., Janssen, Tomas, Dekker, Andre, Vanneste, Ben, Minken, Andre, Hoekstra, Carel, Smeenk, Robert J., van Oort, Inge M., Bangma, Chris H., Incrocci, Luca, Aben, Katja K. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662556/ https://www.ncbi.nlm.nih.gov/pubmed/34900722 http://dx.doi.org/10.3389/fonc.2021.771956 |
Ejemplares similares
-
The Risk of Second Primary Cancers in Prostate Cancer Survivors Treated in the Modern Radiotherapy Era
por: Jahreiß, Marie-Christina, et al.
Publicado: (2020) -
Association between incidental dose outside the prostate and tumor control after modern image-guided radiotherapy
por: Witte, Marnix, et al.
Publicado: (2021) -
Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020) -
Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer
por: Baker, Sarah, et al.
Publicado: (2020) -
Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results
por: Aluwini, Shafak, et al.
Publicado: (2013)